Literature DB >> 24012341

Radiation as an immune modulator.

Byron Burnette1, Ralph R Weichselbaum.   

Abstract

Radiation therapy is currently one of the most widely utilized treatment strategies in the clinical management of cancer. Classically, radiation therapy was developed as an anticancer treatment on the basis of its capacity to induce DNA double strand breaks in exposed cancer cells, ultimately resulting in tumor cell death. Recently, our understanding of radiation effects has expanded widely in terms of the consequences of radiation-induced tumor cell death and the pertinent cells, signaling pathways, and molecular sensors that modify the tumor response to radiation. It is now well accepted that inflammation plays a complex dual role in promoting or inhibiting tumor growth. The capacity of inflammatory responses to alter the tumor response to radiation therapy, and vice versa, is now the subject of intense scientific and clinical investigation. Herein, we review the concepts regarding the immunostimulatory properties of radiation therapy with particular focus on the effects of radiation therapy on the tumor microenvironment.
© 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24012341     DOI: 10.1016/j.semradonc.2013.05.009

Source DB:  PubMed          Journal:  Semin Radiat Oncol        ISSN: 1053-4296            Impact factor:   5.934


  64 in total

Review 1.  Adapting conventional cancer treatment for immunotherapy.

Authors:  Jian Qiao; Zhida Liu; Yang-Xin Fu
Journal:  J Mol Med (Berl)       Date:  2016-02-24       Impact factor: 4.599

Review 2.  Immunological interactions in radiotherapy-opening a new window of opportunity.

Authors:  Tapesh Bhattacharyya; Kiran Purushothaman; Sanudev Sadanandan Vadakke Puthiyottil; Atanu Bhattacharjee; Geetha Muttah
Journal:  Ann Transl Med       Date:  2016-02

Review 3.  Beyond sipuleucel-T: immune approaches to treating prostate cancer.

Authors:  Michael L Cheng; Lawrence Fong
Journal:  Curr Treat Options Oncol       Date:  2014-03

Review 4.  Radiotherapy and immunotherapy: a beneficial liaison?

Authors:  Ralph R Weichselbaum; Hua Liang; Liufu Deng; Yang-Xin Fu
Journal:  Nat Rev Clin Oncol       Date:  2017-01-17       Impact factor: 66.675

Review 5.  Emerging Treatment Paradigms in Radiation Oncology.

Authors:  Quynh-Thu Le; Hiroki Shirato; Amato J Giaccia; Albert C Koong
Journal:  Clin Cancer Res       Date:  2015-05-19       Impact factor: 12.531

6.  Enhancing the efficacy of radiation therapy: premises, promises, and practicality.

Authors:  C Norman Coleman; Theodore S Lawrence; David G Kirsch
Journal:  J Clin Oncol       Date:  2014-08-11       Impact factor: 44.544

7.  Tumor-infiltrating lymphocytes favor the response to chemoradiotherapy of head and neck cancer.

Authors:  Panagiotis Balermpas; Franz Rödel; Christian Weiss; Claus Rödel; Emmanouil Fokas
Journal:  Oncoimmunology       Date:  2014-01-01       Impact factor: 8.110

Review 8.  Molecular radiobiology: the state of the art.

Authors:  Amato J Giaccia
Journal:  J Clin Oncol       Date:  2014-08-11       Impact factor: 44.544

Review 9.  Radiation as immunomodulator: implications for dendritic cell-based immunotherapy.

Authors:  Robert E Roses; Jashodeep Datta; Brian J Czerniecki
Journal:  Radiat Res       Date:  2014-07-03       Impact factor: 2.841

Review 10.  Immune Effects of Chemotherapy, Radiation, and Targeted Therapy and Opportunities for Combination With Immunotherapy.

Authors:  Jennifer A Wargo; Alexandre Reuben; Zachary A Cooper; Kevin S Oh; Ryan J Sullivan
Journal:  Semin Oncol       Date:  2015-06-03       Impact factor: 4.929

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.